Entera Bio Ltd.

ENTXWSEC EDGAR

Biological Products, (No Diagnostic Substances)(L3)CIK: 1638097

Concept	FY2024	FY2023	FY2022	FY2021
Revenues	$0.00	$134.0K	$571.0K	$365.0K
Cost of Revenue	$0.00	$101.0K	$373.0K	$300.0K
Gross Profit	$0.00	$33.0K	$198.0K	$65.0K
Research and Development Expense	$4.5M	$5.8M	$6.8M	$6.4M
Operating Expenses	$8.9M	$13.1M	$12.4M	$11.2M
Operating Income (Loss)	-$8.9M	-$13.0M	-$12.2M	-$11.2M
Nonoperating Income (Expense)	$31.0K	$83.0K	-$29.0K	-$28.0K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$8.9M	-$12.9M	-$12.2M	-$11.2M

Concept	FY2024	FY2023	FY2022	FY2021
Assets	$11.8M	$13.1M	$26.0M	$9.7M
Assets, Current	$11.3M	$12.8M	$25.3M	$9.1M
Cash and Cash Equivalents, at Carrying Value	$11.0M	$12.3M	$24.9M	$8.6M
Accounts Receivable, after Allowance for Credit Loss, Current	$0.00	$246.0K	$183.0K	$255.0K
Liabilities	$1.4M	$1.4M	$3.4M	$2.2M
Liabilities, Current	$1.1M	$1.3M	$3.2M	$1.8M
Accounts Payable, Current	$83.0K	$17.0K	$166.0K	$164.0K
Stockholders' Equity Attributable to Parent	$11.8M	$22.6M	$7.5M	$13.8M

Concept	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$7.3M	-$12.5M	-$9.1M	-$10.6M
Net Cash Provided by (Used in) Investing Activities	-$17.0K	-$102.0K	-$17.0K	-$53.0K
Net Cash Provided by (Used in) Financing Activities	$6.0M	$13.0K	$25.4M	$4.1M
Payments to Acquire Property, Plant, and Equipment	$17.0K	$47.0K	$17.0K	$53.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)